269 related articles for article (PubMed ID: 21184155)
1. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.
Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL
J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155
[TBL] [Abstract][Full Text] [Related]
2. Mutational landscape of severe combined immunodeficiency patients from Turkey.
Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
[TBL] [Abstract][Full Text] [Related]
3. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE review.
Kalman L; Lindegren ML; Kobrynski L; Vogt R; Hannon H; Howard JT; Buckley R
Genet Med; 2004; 6(1):16-26. PubMed ID: 14726805
[TBL] [Abstract][Full Text] [Related]
4. IL7R and RAG1/2 genes mutations/polymorphisms in patients with SCID.
Safaei S; Pourpak Z; Moin M; Houshmand M
Iran J Allergy Asthma Immunol; 2011 Jun; 10(2):129-32. PubMed ID: 21625022
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
[TBL] [Abstract][Full Text] [Related]
6. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
[TBL] [Abstract][Full Text] [Related]
7. Novel RAG1 mutation and the occurrence of mycobacterial and Chromobacterium violaceum infections in a case of leaky SCID.
Khan TA; Iqbal A; Rahman H; Cabral-Marques O; Ishfaq M; Muhammad N
Microb Pathog; 2017 Aug; 109():114-119. PubMed ID: 28552805
[TBL] [Abstract][Full Text] [Related]
8. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
9. B-cell differentiation and IL-21 response in
Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
[TBL] [Abstract][Full Text] [Related]
10. Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3.
Goldberg L; Simon AJ; Lev A; Barel O; Stauber T; Kunik V; Rechavi G; Somech R
Genes Immun; 2020 Nov; 21(5):326-334. PubMed ID: 32921793
[TBL] [Abstract][Full Text] [Related]
11. Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.
Sundin M; Marits P; Ramme K; Kolios AGA; Nilsson J
Clin Immunol; 2019 Mar; 200():16-18. PubMed ID: 30630113
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and genetic profiles of 44 patients with severe combined immunodeficiency (SCID): report from Shanghai, China (2004-2011).
Yao CM; Han XH; Zhang YD; Zhang H; Jin YY; Cao RM; Wang X; Liu QH; Zhao W; Chen TX
J Clin Immunol; 2013 Apr; 33(3):526-39. PubMed ID: 23250629
[TBL] [Abstract][Full Text] [Related]
13. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
14. Whole-exome sequencing of T
El Hawary R; Meshaal S; Mauracher AA; Opitz L; Abd Elaziz D; Lotfy S; Eldash A; Boutros J; Galal N; Pachlopnik Schmid J; Elmarsafy A
Clin Exp Immunol; 2021 Mar; 203(3):448-457. PubMed ID: 33040328
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Genetic Defects in Severe Combined Immunodeficiency Patients from Turkey by Targeted Sequencing.
Erman B; Bilic I; Hirschmugl T; Salzer E; Boztug H; Sanal Ö; Çağdaş Ayvaz D; Tezcan I; Boztug K
Scand J Immunol; 2017 Mar; 85(3):227-234. PubMed ID: 28109013
[TBL] [Abstract][Full Text] [Related]
16. A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency.
Khanolkar A; Wilks JD; Liu G; Simpson BM; Caparelli EA; Kirschmann DA; Bergerson J; Fuleihan RL
Immunol Res; 2020 Feb; 68(1):13-27. PubMed ID: 32215810
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.
Dvorak CC; Haddad E; Heimall J; Dunn E; Cowan MJ; Pai SY; Kapoor N; Satter LF; Buckley RH; O'Reilly RJ; Chandra S; Bednarski JJ; Williams O; Rayes A; Moore TB; Ebens CL; Davila Saldana BJ; Petrovic A; Chellapandian D; Cuvelier GDE; Vander Lugt MT; Caywood EH; Chandrakasan S; Eissa H; Goldman FD; Shereck E; Aquino VM; Desantes KB; Madden LM; Miller HK; Yu L; Broglie L; Gillio A; Shah AJ; Knutsen AP; Andolina JP; Joshi AY; Szabolcs P; Kapadia M; Martinez CA; Parrot RE; Sullivan KE; Prockop SE; Abraham RS; Thakar MS; Leiding JW; Kohn DB; Pulsipher MA; Griffith LM; Notarangelo LD; Puck JM
J Allergy Clin Immunol; 2023 Feb; 151(2):547-555.e5. PubMed ID: 36456360
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of hematopoietic stem cell transplantation for IL2RG/JAK3 SCID: a cohort report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
Blood; 2017 Apr; 129(15):2198-2201. PubMed ID: 28209722
[TBL] [Abstract][Full Text] [Related]
19. Severe combined immunodeficiencies: Expanding the mutation spectrum in Turkey and identification of 12 novel variants.
Aykut A; Durmaz A; Karaca N; Gulez N; Genel F; Celmeli F; Ozturk G; Atay D; Aydogmus C; Kiykim A; Aksu G; Kutukculer N
Scand J Immunol; 2022 Jun; 95(6):e13163. PubMed ID: 35303369
[TBL] [Abstract][Full Text] [Related]
20. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
